Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 purchases).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
AMYRIS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $91.5K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $75K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $85.8K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $151K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $116.3K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $76.4K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $143.1K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $137.5K | SEC | ||
AMYRIS, INC.Listing unverified | Sell | $23.9K | SEC | ||
AMYRIS, INC.Listing unverified | BuyD (derivative) | $35T | Cluster | SEC | |
AMYRIS, INC.Listing unverified | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Cluster | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Buy | $10.2M | conv 33First in 12mo | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
PORTOLA PHARMACEUTICALS INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC |